Back to search
FDAFDA · Food and drugs·Recall number Z-1781-2017

Boston Scientific Imager II Angiographic Catheter, M001316581 (5-pack outer package UPN), M001316580, single unit, inner package UPN)

Published April 19, 2017 · Recall initiated: December 13, 2016

Summary

FDA records medical device Class II recall Z-1781-2017, published April 19, 2017 and initiated December 13, 2016. Recalling firm: Boston Scientific Corporation; Status: Terminated; Reported quantity: 26 boxes of 5 (130 singles); Lot: Lot: 00116127, Expiration Date: September 30, 2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

One lot of Imager II Angiographic Catheters is being recalled due to packaging mislabeling. The product may be labeled as Imager II Contra 2 curve catheters, when in fact the package contains Contra curve catheters.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boston Scientific Corporation
Distributor
AZ, FL, MO, NJ, NY, OH, PA, and TX.
Lot
Lot: 00116127, Expiration Date: September 30, 2018
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Boston Scientific Imager II Angiographic Catheter, M001316581 (5-pack outer package UPN), M001316580, single unit, inner package UPN) recalled?

Yes. FDA published recall Z-1781-2017 on April 19, 2017. Reported hazard: One lot of Imager II Angiographic Catheters is being recalled due to packaging mislabeling. The product may be labeled as Imager II Contra 2 curve catheters, when in fact the package contains Contra curve catheters.

What should I do if I have this product?

Voluntary: Firm initiated · Letter